![]() Catalyst Pharmaceuticals Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases. | ![]() scPharmaceuticals scPharmaceuticals, a biopharmaceutical company, develops a portfolio of transformative pharmaceutical products for subcutaneous delivery. | ||
Founding Date | Founding Date 2005 | Founding Date 2002 | Founding Date 2014 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ | Locations Coral Gables, US HQ | Locations Burlington, US HQ |
Employees | Employees 4235% decrease | Employees 7649% increase | Employees 96256% increase |
Valuation ($) | Valuation ($) 131.1 m | Valuation ($) 2.6 b | Valuation ($) 221.6 m |
Financial | |||
Revenue (est.) | Revenue (est.) $190k (FY, 2025) | Revenue (est.) $589m (FY, 2025) | Revenue (est.) $36.3m (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods $87.3m (FY, 2025) | Cost of goods $11.4m (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit $501.7m (FY, 2025) | Gross profit $25m (FY, 2024) |
Net income | Net income ($74.1m) (FY, 2025) | Net income $214.3m (FY, 2025) | Net income ($85.1m) (FY, 2024) |

Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases.
View company
scPharmaceuticals, a biopharmaceutical company, develops a portfolio of transformative pharmaceutical products for subcutaneous delivery.
View company